Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 2 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar kkconway (99.16) Submitted: 11/17/2012 12:35:25 PM : Outperform Start Price: $20.90 INFI Score: -23.52

Rheumatoid arthritis drug with great promise. I would not bet the farm on this, but it should be a multi-bagger if -IF - their new drug is a hit.

Featured Broker Partners


Advertisement